A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome

Peer Review reports

Original Submission
4 Aug 2011	Submitted	Original manuscript
26 Sep 2011	Author responded	Author comments - Peter Rhode
Resubmission - Version 2
26 Sep 2011	Submitted	Manuscript version 2
17 Nov 2011	Reviewed	Reviewer Report - Kathleen Liu
18 Nov 2011	Reviewed	Reviewer Report - Jason Roberts
12 Dec 2011	Author responded	Author comments - Peter Rhode
Resubmission - Version 3
12 Dec 2011	Submitted	Manuscript version 3
Publishing
16 Feb 2012	Editorially accepted
16 Feb 2012	Article published	10.1186/1471-2466-12-5

Back to article page